42.03 USD
↘ 3.44 (7.57%)LIVE (AS OF 12:50 PM EDT)
Enliven Therapeutics, Inc. Common Stock
ELVNNASDAQ • USD
Market: OPEN
ELVN is currently priced at $42.03. The technical outlook is "Strong Sell" and the fundamental picture shows "Neutral". This is driven by a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bullish Golden Cross on the moving averages. On valuation, ELVN trades roughly in line with sector averages — neither particularly cheap nor expensive.
Technical & fundamental data as of Oct 5, 2026.
Open?$45.38
High?$45.87
Low?$41.29
Prev. Close?$45.47
Volume?780.5K
Avg. Volume?1.3M
VWAP?$42.54
Rel. Volume?0.60x
Bid / Ask
Bid?$42.25 × 100
Ask?$42.62 × 100
Spread?$0.37
Midpoint?$42.44
Valuation & Ratios
Market Cap?3.3B
Shares Out?73.3M
Float?60.8M
Float %?83.0%
P/E Ratio?N/A
P/B Ratio?3.72
EPS?-$1.45
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics. The product candidates of the company include ELVN-001 is designed to specifically target the BCR-ABL fusion gene product, the oncogenic driver for patients with chronic myeloid leukemia (CML), ELVN-002 is designed to inhibit wild-type HER2 and key mutations of HER2.
Employees
67
Market Cap
3.3B
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2023-02-24
Address
205 PARK ROAD
BURLINGAME, CA 94010
Phone: 650-547-5814
BURLINGAME, CA 94010
Phone: 650-547-5814
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-1/3)
Medium-Term (Wave)?▼ Bearish(-3/3)
Short-Term (Ripple)?▼ Bearish(-1/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?100
Momentum?50
Short Sent.?34
Piotroski F-Score?0/9Weak
Altman Z-Score?132.72Safe
Confidence?52%Low
Short InterestHigh
Short % of Float?14.17%High
Short Interest?8.6M
Days to Cover?9.0
Free Float60.8M
Avg Daily Volume956.5K
Settlement Date2026-09-15
Financial Health
Current Ratio?64.07Strong
Quick Ratio?64.07Strong
Cash Ratio?9.57Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score83/100
P/E?N/A▾
P/B?3.72FAIR▾
Peers100
S&P47
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-25.7CHEAP▾
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?-11.8%WEAK▾
S&P9
ROA?-11.6%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-67037000
Enterprise Value?$3.2B
Fundamentals ratios updated end of day